Background Although the efficacy and safety of monotherapy in the treatment of benign
prostatic hyperplasia (BPH) have been established clinically, the efficacy and safety of …

Benign prostatic hyperplasia (BPH) mainly causes lower urinary tract symptoms in ageing
men, but its exact etiology and pathogenesis have not been established. The objective of …

Gastrointestinal disorders in Parkinson's disease (PD) have been associated with neuronal
alteration in the plexus of the gut. We previously demonstrated the immunomodulatory effect …

Although hair loss contributes to various social and economic, research methods for material
development are currently limited. In this study, we established a research model for …

This chapter reviews acquired hair disorders, including common scarring and non‐scarring
alopecia presentations, conditions characterised by excessive body hair growth and …

Background Based on our observations at the largest outpatient urology clinic in Iran,
patients for whom finasteride is prescribed as a secondary drug to tamsulosin tend to …

Purpose Finasteride and dutasteride are used to treat benign prostatic hyperplasia (BPH)
and reduce the risk of developing prostate cancer. Finasteride blocks only the type 2 form of …

В современной клинической практике для лечения доброкачественной гиперплазии
предстательной железы применяется большой спектр хирургических вмешательств с …

Objectives: Benign prostatic hyperplasia (BPH) is a progressive pathological condition
characterized by excessive proliferation of the prostate. In this study, we evaluated the effect …

Benign prostatic hyperplasia (BPH) is a benign enlargement of the prostatic gland. This
study was conducted to measure the improvement of prostate volume after treatment with …